*Burkholderia thailandensis* is a member of the *Burkholderia pseudomallei* complex and is generally considered nonpathogenic ([@R1]). *B. pseudomallei* causes the disease melioidosis and can be fatal even when properly treated ([@R1]--[@R3]). *B. thailandensis* was first discovered in Thailand and was differentiated from *B. pseudomallei* phenotypically by its ability to assimilate arabinose ([@R3]). *B. thailandensis*, like *B. pseudomallei*, naturally occurs in the environment (e.g., in moist soils) and is associated with tropical or subtropical climates ([@R3],[@R4]). Environmental isolates of *B. thailandensis* have been predominantly recovered in Southeast Asia, with sporadic reports in other regions such as in Australia, which is considered the ancestral origin for *B. pseudomallei* based on analysis of genomic single-nucleotide polymorphisms (SNPs) ([@R4]--[@R6]).

The phenotypic similarities are substantial among members of the *B. pseudomallei* complex, other *Burkholderia* species, and other bacteria such as *Pseudomonas* spp. Laboratory personnel unfamiliar with *B. pseudomallei* often have difficulty identifying it using microbiologic methods commonly available in clinical settings. Automated biochemical systems might also misidentify *B. pseudomallei* because of an insufficient number of reference strains in their databases. Incorrect identification can delay appropriate antimicrobial therapy ([@R1],[@R4],[@R7]).

Although rare, *B. thailandensis* infections in humans have been reported. The first case reported in the literature occurred in or before 1999 in Thailand in a 16-year-old boy who suffered compound fractures in a motorcycle accident ([@R8]). The second case occurred in 1997 in a 76-year-old man in Louisiana, USA, who had a pleural wound; this case resulted in recovery of isolate H0587 (also known as CDC2721121). Further details on the wound and whether it was acquired locally or whether the patient had a travel history to areas endemic for *B. thailandensis* are not available. The third case occurred in 2003 in a previously healthy 2-year-old boy in Texas, USA, who aspirated water from a ditch after a car accident; this case resulted in recovery of isolate TXDOH (also known as CDC3015869) ([@R9]). The fourth case occurred in 2011 in a 42-year-old man in Malaysia who had a foot abscess with ankle swelling and skin cellulitis ([@R10]). The fifth report was a fatal case that occurred in 2013 in a 67-year-old man who was treated at a hospital in Chongquing, China ([@R11]); however, subsequent correspondence suggested that the species had been identified incorrectly and was most likely *B. pseudomallei* ([@R12]).

In April 2017, a 29-year-old woman with diabetes in Arkansas, USA, crashed into a large metal trash bin while driving an all-terrain vehicle, resulting in an open bone forearm fracture. Treatment of the wound included installation of a metal plate. Approximately 3 months later, the patient returned to the hospital because of a 2-week history of swelling of her forearm. An isolate was recovered from pure culture graded 1+ (trace growth) from a deep operative tissue specimen from the forearm wound. Initial antimicrobial treatment consisted of piperacillin/tazobactam, vancomycin, and cefazolin. Testing of the isolate using the Microscan Walkaway automated biochemical system (Beckman Coulter, Atlanta, GA, USA) by the hospital laboratory identified *B. pseudomallei*. Based on this result, the Arkansas Department of Health (DoH) contacted the Centers for Disease Control and Prevention (CDC) about a suspected case of melioidosis. After the hospital transferred the isolate to the Arkansas DoH, *B. pseudomallei* was ruled out by using biochemical and PCR testing. The isolate was presumptively identified as *B. thailandensis* by using the Bruker MALDI Biotyper mass spectrometer (Bruker Daltonics, Billerica, MA, USA). Arkansas DoH forwarded the isolate, designated BtAR2017, to CDC for confirmation and further characterization. The patient was discharged with 6 weeks of intravenous ceftazidime treatment. She last saw her healthcare provider in December 2017 and was reported completely healed.

The Study
=========

Biochemical testing, including arabinose assimilation, identified isolate BtAR2017 as *B. thailandensis*. We extracted DNA from the isolate for next-generation sequencing ([Technical Appendix](#SD1){ref-type="local-data"}). We analyzed the genome of BtAR2017 for multilocus sequence typing (MLST), which yielded sequence type (ST) 101. ST101 was previously identified in *B. thailandensis* isolates TXDOH and H0587 ([@R9]). Although MLST is commonly used to subtype members of the *B. pseudomallei* complex, it has only a moderate level of resolution and, because of recombination, might not reflect actual levels of relatedness ([@R5],[@R13]).

For high-resolution analysis, we compared the genome of BtAR2017 with a reference panel of publicly available *B. thailandensis* genomes ([Table](#T1){ref-type="table"}). A dendrogram based on the SNP analysis indicates that BtAR2017 clusters with H0587 and TXDOH ([Figure](#F1){ref-type="fig"}). Also within the BtAR2017 cluster is E555, an environmental isolate recovered in Cambodia in 2005, and strain 2.1, which metadata in the National Center for Biotechnology Information entry indicate was recovered in June 2017 from soil in Vietnam ([@R14]). This cluster appears as an outlier subgroup compared with other examples of *B. thailandensis,* including E264^T^ (type strain). MLST indicates that E555 is ST696, which is a single-locus variant of ST101. Comparison of the genome sequences indicates \>4,700 core SNPs between BtAR2017 and E555, compared with \>32,700 SNPs between BtAR2017 and E264^T^. BtAR2017 has \>2,200 SNPs compared with H0587 but \>5,900 SNPs compared with TXDOH.

###### Reference *Burkholderia* spp. genomes used for characterization of *Burkholderia thailandensis* isolated from an infected wound, Arkansas, USA, 2017\*

  Isolate                  Other identifiers           Origin             Source          ST†   GenBank accession nos.         ANI   SNP
  ------------------------ --------------------------- ------------------ --------------- ----- ------------------------------ ----- -----
  82172                    34; 2002721621              France             Horse (foal)    73    NZ_LNNG00000000                      X
  Bt4                      49639                       Australia          Environmental   699   NZ_ABBH00000000                      X
  E1                                                   Papua New Guinea   Environmental   669   NZ_LOXF00000000                      X
  E254                                                 Thailand           Environmental   345   NZ_CP004381.1; NZ_CP004382.1         X
  E264                     ATCC 700388                 Thailand           Environmental   80    CP008785.1; CP008786.1         X     X
  E444                                                 Thailand           Environmental   79    NZ_CP004117.1; NZ_CP004118.1         X
  E555                                                 Cambodia           Environmental   696   NZ_AECN00000000                      X
  H0587                    BtCDC2721121; 2002721121    USA (Louisiana)    Human           101   NZ_CP013409.1; NZ_CP013410.1         X
  K96243                                               Thailand           Human           10    NC_006350.1; NC_006351.1       X     
  MSMB59                   MSMB0059                    Australia          Environmental   699   NZ_CP004385.1; NZ_CP004386.1         X
  MSMB60                   MSMB0060                    Australia          Environmental   699   NZ_LOXG00000000                      X
  Phuket 4W-1                                          Thailand           Environmental   80    NZ_AQQJ01000000                      X
  Strain 2.1                                           Vietnam            Environmental   696   PHRD00000000                         X
  TXDOH                    CDC3015869; 2003015869      USA (Texas)        Human           101   NZ_CP013360.1; NZ_CP013361.1   X     X
  USAMRU Malaysia no. 20   Malaysia \#20; 2002721744   Malaysia           Unknown         80    NZ_CP004383.1; NZ_CP004384.1         X

\*X indicates inclusion in analysis. ANI, average nucleotide identity; SNP, single nucleotide polymorphism; ST, sequence type.  †By multilocus sequence typing.
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Sim et al. ([@R14]) previously noted this outlier subgroup and postulated that its members, including E555, might be more virulent than typical examples of *B. thailandensis*. However, their studies challenging BALB/c mice and the nematode *Caenorhabditis elegans* with E555 did not reveal any significant difference in virulence compared with E264^T^ ([@R14]). Another study by Deshazer using TXDOH and H0587 to challenge mice and hamsters indicated that in these models TXDOH also had a similar level of virulence as E264^T^, whereas H0587 was avirulent ([@R15]). E555 is known to have features such as a *B. pseudomallei*--like capsular polysaccharide ([@R14]). We tested BtAR2017 for *B. pseudomallei* capsular polysaccharide, but results were negative.

We analyzed average nucleotide identity (ANI) and determined that the genome for BtAR2017 has 98.99% identity with that of E264^T^, which is above the 95% threshold commonly used for distinguishing species. The BtAR2017 genome also had an ANI of 99.75% compared with TXDOH but only 92.7% compared with K96243, a representative *B. pseudomallei* strain used in lieu of the species type strain. Although BtAR2017 is in the outlier subgroup resolved by genomic SNP analysis, these ANI results suggest that BtAR2017 and other members of the subgroup are *B. thailandensis* and not a novel species.

Conclusions
===========

The recovery of the clinical isolates suggests that *B. thailandensis* might be endemic to the continental United States and capable of causing opportunistic infections associated with traumatic injuries. Because of the limited number of reports, this bacterium's geographic range in North America is unknown. Two of the 3 clinical isolates recovered in the United States are now well documented and were acquired in the southern states of Texas and Arkansas, possibly reflecting the affinity for warm climates associated with most members of the *B. pseudomallei* complex (the exception being *B. mallei*, which is host-adapted to equids and does not persist in the environment). These 3 clinical isolates also are members of the outlier subgroup on the dendrogram ([Figure](#F1){ref-type="fig"}), which suggests a genetic bottleneck or discrete seeding event for the United States, assuming the Louisiana case was acquired locally. Further study of *B. thailandensis* will improve our knowledge of its geographic range and ability to cause infections.

###### Technical Appendix

Materials and methods used for characterization of *Burkholderia thailandensis* isolated from an infected wound, Arkansas, USA, 2017.
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